These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22664457)

  • 21. B cell depletion: on the rise.
    Hinze CH; Grom AA
    J Pediatr; 2007 Apr; 150(4):335-7. PubMed ID: 17382106
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anti-B-cell strategies in autoimmune diseases].
    Müller-Ladner U
    Z Rheumatol; 2009 Jul; 68(5):363. PubMed ID: 19513728
    [No Abstract]   [Full Text] [Related]  

  • 23. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.
    Silverman GJ; Weisman S
    Arthritis Rheum; 2003 Jun; 48(6):1484-92. PubMed ID: 12794814
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular engineering of antibodies for therapeutic and diagnostic purposes.
    Ducancel F; Muller BH
    MAbs; 2012; 4(4):445-57. PubMed ID: 22684311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Efficient Method to Generate Monoclonal Antibodies from Human B Cells.
    Guthmiller JJ; Dugan HL; Neu KE; Lan LY; Wilson PC
    Methods Mol Biol; 2019; 1904():109-145. PubMed ID: 30539468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic antibodies and antibody fusion proteins.
    Rohrbach P; Broders O; Toleikis L; Dübel S
    Biotechnol Genet Eng Rev; 2003; 20():137-63. PubMed ID: 14997850
    [No Abstract]   [Full Text] [Related]  

  • 27. B-lymphocyte contributions to human autoimmune disease.
    Yanaba K; Bouaziz JD; Matsushita T; Magro CM; St Clair EW; Tedder TF
    Immunol Rev; 2008 Jun; 223():284-99. PubMed ID: 18613843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Next-Generation Techniques for Discovering Human Monoclonal Antibodies].
    Lushova AA; Biazrova MG; Prilipov AG; Sadykova GK; Kopylov TA; Filatov AV
    Mol Biol (Mosk); 2017; 51(6):899-906. PubMed ID: 29271955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understand memory, design better vaccines.
    Bevan MJ
    Nat Immunol; 2011 Jun; 12(6):463-5. PubMed ID: 21587308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CD20 antibody for the treatment of systemic autoimmune diseases].
    Tanaka Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():728-33. PubMed ID: 15954437
    [No Abstract]   [Full Text] [Related]  

  • 31. B cells move to centre stage: novel opportunities for autoimmune disease treatment.
    Browning JL
    Nat Rev Drug Discov; 2006 Jul; 5(7):564-76. PubMed ID: 16816838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (rituximab).
    Kain S; Copeland TS; Leahy MF
    Br J Haematol; 2002 Nov; 119(2):578. PubMed ID: 12406107
    [No Abstract]   [Full Text] [Related]  

  • 33. Understanding and making use of human memory B cells.
    Lanzavecchia A; Bernasconi N; Traggiai E; Ruprecht CR; Corti D; Sallusto F
    Immunol Rev; 2006 Jun; 211(1):303-9. PubMed ID: 16824137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
    Looney RJ
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-cell depletion and repopulation in autoimmune diseases.
    Pers JO; Daridon C; Bendaoud B; Devauchelle V; Berthou C; Saraux A; Youinou P
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):50-5. PubMed ID: 18270858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single B cell antibody technologies.
    Tiller T
    N Biotechnol; 2011 Sep; 28(5):453-7. PubMed ID: 21473940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic antibody engineering by high efficiency cell screening.
    Doerner A; Rhiel L; Zielonka S; Kolmar H
    FEBS Lett; 2014 Jan; 588(2):278-87. PubMed ID: 24291259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B cell reductive therapy in the treatment of autoimmune diseases: a focus on monoclonal antibody treatment of rheumatoid arthritis.
    Tuscano JM; Martin S; Song K; Wun T
    Hematology; 2005 Dec; 10(6):521-7. PubMed ID: 16321818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of autoimmune and lymphoproliferative complications of patients with intrinsic B-cell immunodeficiencies with Rituximab.
    Hennig C; Baumann U; Ilginus C; Horneff G; Foell J; Hansen G
    Br J Haematol; 2010 Feb; 148(3):445-8. PubMed ID: 19922533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of a diverse repertoire of human antibodies in genetically engineered mice.
    Ishida I; Yoshida H; Tomizuka K
    Microbiol Immunol; 1998; 42(3):143-50. PubMed ID: 9570278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.